STOCK TITAN

Boston Scientific announces upcoming investor conference schedule

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Analysis in progress...
Boston Scientific (NYSE: BSX) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel maggio 2025. Il 13 maggio, durante la Bank of America's 2025 Health Care Conference, EVP/CFO Dan Brennan e EVP/Group President of Cardiology Joe Fitzgerald parteciperanno a una sessione di domande e risposte di 30 minuti, con inizio alle 11:00 ET. Successivamente, il 28 maggio, Chairman/CEO Mike Mahoney e SVP/Global Chief Medical Officer Ken Stein prenderanno parte a una sessione di Q&A di 50 minuti alla Bernstein's 41st Annual Strategic Decisions Conference, a partire dalle 8:00 ET. Entrambi gli eventi saranno trasmessi in diretta via webcast e disponibili in replay sul sito web delle relazioni con gli investitori dell'azienda.
Boston Scientific (NYSE: BSX) ha anunciado su participación en dos importantes conferencias para inversores en mayo de 2025. El 13 de mayo, en la Bank of America's 2025 Health Care Conference, EVP/CFO Dan Brennan y EVP/Group President of Cardiology Joe Fitzgerald participarán en una sesión de preguntas y respuestas de 30 minutos a partir de las 11:00 a.m. ET. Más tarde, el 28 de mayo, el Chairman/CEO Mike Mahoney y el SVP/Global Chief Medical Officer Ken Stein participarán en una sesión de Q&A de 50 minutos en la Bernstein's 41st Annual Strategic Decisions Conference, comenzando a las 8:00 a.m. ET. Ambos eventos estarán disponibles vía webcast en vivo y en repetición en el sitio web de relaciones con inversores de la compañía.
Boston Scientific (NYSE: BSX)는 2025년 5월에 열리는 두 개의 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 5월 13일 Bank of America's 2025 Health Care Conference에서 EVP/CFO Dan Brennan과 EVP/Group President of Cardiology Joe Fitzgerald가 오전 11시(ET)부터 30분간 질의응답 세션을 진행합니다. 이어서 5월 28일에는 Chairman/CEO Mike Mahoney와 SVP/Global Chief Medical Officer Ken Stein이 오전 8시(ET)부터 시작되는 Bernstein's 41st Annual Strategic Decisions Conference에서 50분간 질의응답 세션에 참여합니다. 두 행사 모두 회사 투자자 관계 웹사이트에서 라이브 웹캐스트 및 다시보기로 제공됩니다.
Boston Scientific (NYSE : BSX) a annoncé sa participation à deux grandes conférences pour investisseurs en mai 2025. Le 13 mai, lors de la Bank of America's 2025 Health Care Conference, le EVP/CFO Dan Brennan et le EVP/Group President of Cardiology Joe Fitzgerald animeront une session de questions-réponses de 30 minutes à partir de 11h00 ET. Ensuite, le 28 mai, le Chairman/CEO Mike Mahoney et le SVP/Global Chief Medical Officer Ken Stein prendront part à une session de Q&A de 50 minutes lors de la Bernstein's 41st Annual Strategic Decisions Conference, débutant à 8h00 ET. Les deux événements seront diffusés en direct via webcast et disponibles en replay sur le site des relations investisseurs de la société.
Boston Scientific (NYSE: BSX) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Mai 2025 angekündigt. Am 13. Mai werden EVP/CFO Dan Brennan und EVP/Group President of Cardiology Joe Fitzgerald auf der Bank of America's 2025 Health Care Conference eine 30-minütige Fragerunde ab 11:00 Uhr ET durchführen. Am 28. Mai nehmen Chairman/CEO Mike Mahoney und SVP/Global Chief Medical Officer Ken Stein an einer 50-minütigen Fragerunde auf der Bernstein's 41st Annual Strategic Decisions Conference ab 8:00 Uhr ET teil. Beide Veranstaltungen werden live per Webcast übertragen und können auf der Investor-Relations-Website des Unternehmens auch im Nachhinein angesehen werden.
Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., May 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

On May 13, 2025, Dan Brennan, executive vice president and chief financial officer, and Joe Fitzgerald, executive vice president and group president, Cardiology, will participate in a 30-minute question-and-answer session with the host analyst at Bank of America's 2025 Health Care Conference. The session will begin at approximately 8:00 a.m. PT / 11:00 a.m. ET.

On May 28, 2025, Mike Mahoney, chairman and chief executive officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 50-minute question-and-answer session with the host analyst at Bernstein's 41st Annual Strategic Decisions Conference. The session will begin at approximately 8:00 a.m. ET.

A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X.  

CONTACTS:
Chanel Hastings
Media Relations
(508) 382-0288 (office)
Chanel.Hastings@bsci.com 

Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-upcoming-investor-conference-schedule-302442449.html

SOURCE Boston Scientific Corporation

FAQ

When is Boston Scientific (BSX) presenting at Bank of America's Health Care Conference 2025?

Boston Scientific will present at Bank of America's Health Care Conference on May 13, 2025, at 11:00 a.m. ET with a 30-minute Q&A session featuring EVP/CFO Dan Brennan and EVP Joe Fitzgerald.

Who will represent Boston Scientific (BSX) at Bernstein's Strategic Decisions Conference 2025?

Chairman/CEO Mike Mahoney and SVP/Global Chief Medical Officer Ken Stein will represent Boston Scientific at Bernstein's Conference on May 28, 2025.

How can I watch Boston Scientific's (BSX) investor conference presentations in May 2025?

Both conference presentations will be available via live webcast and replay at https://investors.bostonscientific.com, with replays available approximately one hour after each event.

What time is Boston Scientific's (BSX) presentation at Bernstein's Conference on May 28, 2025?

Boston Scientific's 50-minute Q&A session at Bernstein's Conference will begin at 8:00 a.m. ET on May 28, 2025.
Boston Scien Cp

NYSE:BSX

BSX Rankings

BSX Latest News

BSX Stock Data

150.72B
1.47B
0.2%
93.36%
0.87%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MARLBOROUGH